Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements
A Prospective, Multi-Centre Study on Costs and Effects of Waiting Time in Patients Undergoing Total Hip and Knee Replacement Surgery. A Randomized Controlled Trial.
1 other identifier
interventional
833
1 country
1
Brief Summary
The aim of this study is to compare the cost-effectiveness of major joint replacement in patients with short and non-fixed (control group) waiting time (WT). After being placed on the waiting list, patients will be randomized into two groups through regular contact with the practice staff: (1) Patients with non-fixed waiting time (patient undergoes hospital's normal procedure from the date (s)he is added to the waiting list to the date of operation), and (2) patients with short waiting time (operated in maximum three months). The main question is: is it possible to improve the cost-effectiveness of major joint replacement by shortening waiting time?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2002
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2002
CompletedFirst Submitted
Initial submission to the registry
February 21, 2006
CompletedFirst Posted
Study publicly available on registry
February 22, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFebruary 22, 2006
January 1, 2006
February 21, 2006
February 21, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The generic, 15-dimensional and standardised health status instrument 15D
when placed on the waiting list, at admission, 3 months and 12 months after surgery
Secondary Outcomes (20)
Modified Harris Hip Score
Modified Knee Score
10-cm horizontal visual analog scale (VAS)
Perceived health on a scale 1-5: excellent, very good, good, moderate and poor
Use and costs of health services
- +15 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- a need for a primary unilateral or bilateral THR (total hip replacement) or TKR (total knee replacement) due to osteoarthritis (OA) evaluated by the orthopaedic surgeon
- aged 16 years or older
- female or male
- patient is placed on the waiting list in a research hospital
- the patent is willing and mentally able to participate in the study.
You may not qualify if:
- Subjects with rheumatoid arthritis
- Subjects with fractures
- Subjects with haemophilia
- Subjects with congenital deformities
- Subjects with a need for re-arthroplasty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Academy of Finlandlead
- Hospital District of Helsinki and Uusimaacollaborator
- Coxa, Hospital for Joint Replacementcollaborator
- Tampere Universitycollaborator
- Orton Invalid Foundationcollaborator
Study Sites (1)
Stakes/National Research and Development Centre for Welfare and Health
Helsinki, Helsinki, 00531, Finland
Related Publications (1)
Sintonen H. 2001. The 15D instrument of health-related quality of life: properties and applications. The Finnish Medical Society Duodecim, Ann Med 33: 328-336 Sintonen H. http://www.15d-instrument.net/15d Drummond M. 2001. Introducing economic and quality of life measurements into clinical studies. Ann Med 33: 344-353 Mahomed NN, Arndt DC, McGrory BJ, Harris WH. The Harris Hip Score. Comparison of patient self-report with surgeon assessment. J Arthroplasty 2001; 16: 575-580 Insall JN, Lawrence DD, Scott RD, Scott WN. 1989. Rationale of The Knee Society Clinical Rating System. Clin Orthop. 248: 13-14 McDowell I, Newell C. 1996. Measuring Health: A Guide to Rating Scales and Questionnaires, 2nd edn. New York: Oxford University Press Hujanen T. Unit cost of health care in Finland 2001. Helsinki: Stakes. Aiheita 1/2003 (in Finnish) Pharmaca Fennica. CD-Pharmaca. 2004. Lääketietokeskus (in Finnish)
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marja L Blom, PhD
Academy Of Finland/ Stakes/ National Research and Development Centre for Welfare and Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 21, 2006
First Posted
February 22, 2006
Study Start
September 1, 2002
Study Completion
April 1, 2006
Last Updated
February 22, 2006
Record last verified: 2006-01